This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy with Drs. Vamsidhar Velcheti, Sylvia Adams, Claire Friedman, and Gulam A. Manji.
Register for a free, virtual event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
The Fifth CRI-CIMT-EATI-AACR CICON takes place September 25-28, 2019, at Espace Grand Arche de la Défense in Paris, France.
On Monday, October 7, 2019, at The Rainbow Room, the Cancer Research Institute bestows its highest honors on those who are dedicated to fueling the development of immunotherapies for all forms of cancer.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy with Drs. Adi Diab, Jianjun Gao, Andrew Sikora, and Valentina Hoyos Velez.
The Cancer Research Institute assembles a team to run the 2019 TCS New York City Marathon.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.
The Sixth CRI-CIMT-EATI-AACR CICON takes place September 13-16, 2020, at the New York Marriott Marquis in New York City.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
July is Sarcoma Awareness Month. As a rare and difficult-to-treat form of cancer, effective drug treatments are urgently needed and immunotherapy for sarcoma shows promise.
Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research and the recently launched partnership with CRI.